Fig. 2From: Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysisDuration of vaccine effectiveness against each variant of concern. Points with error bars are VEs and 95% CIs of primary series and booster doses against different VOC and time since vaccination. “VOC_Time” includes days since the last dose vaccination during each variant of concern, “ − 90” means 14–90 days, “ − 180” means 91–180 days, and “ − 180 + ” means ≥ 180 days. Dotted lines were the LOESS smoothing curves, indicating VE variation tendency. Effectiveness of inactivated SARS-CoV-2 vaccines for the primary series against SARS-CoV-2 infection waned over time since vaccination and VOC and was restored by booster doses during Delta and Omicron periods; effectiveness against severe COVID-19 was much greater compared to the effectiveness against infection, improved when boosted during Delta and Omicron periodsBack to article page